Literature DB >> 31235932

TREM2 function impedes tau seeding in neuritic plaques.

Cheryl E G Leyns1,2,3, Maud Gratuze1,2,3, Sneha Narasimhan4, Nimansha Jain1,2,3, Lauren J Koscal1,2,3, Hong Jiang1,2,3, Melissa Manis1,2,3, Marco Colonna2,3,5, Virginia M Y Lee4, Jason D Ulrich6,7,8, David M Holtzman9,10,11.   

Abstract

Variants in the triggering receptor expressed on myeloid cells 2 (TREM2) have been associated with increased risk for sporadic, late-onset Alzheimer's disease. Here we show that germline knockout of Trem2 or the TREM2R47H variant reduces microgliosis around amyloid-β plaques and facilitates the seeding and spreading of neuritic plaque tau aggregates. These findings demonstrate a key role for TREM2 and microglia in limiting the development of peri-plaque tau pathologies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31235932      PMCID: PMC6660358          DOI: 10.1038/s41593-019-0433-0

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  69 in total

Review 1.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

2.  Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.

Authors:  Wenhui Qu; Ling Li
Journal:  J Neurosci       Date:  2020-11-02       Impact factor: 6.167

3.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

4.  A Multifunctional Chemical Agent as an Attenuator of Amyloid Burden and Neuroinflammation in Alzheimer's Disease.

Authors:  Hong-Jun Cho; Anuj K Sharma; Ying Zhang; Michael L Gross; Liviu M Mirica
Journal:  ACS Chem Neurosci       Date:  2020-05-04       Impact factor: 4.418

Review 5.  Leveraging preclinical models for the development of Alzheimer disease therapeutics.

Authors:  Kimberly Scearce-Levie; Pascal E Sanchez; Joseph W Lewcock
Journal:  Nat Rev Drug Discov       Date:  2020-04-08       Impact factor: 84.694

6.  Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses.

Authors:  Kirby M Donnelly; Olivia R DeLorenzo; Aprem DA Zaya; Gabrielle E Pisano; Wint M Thu; Liqun Luo; Ron R Kopito; Margaret M Panning Pearce
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

Review 7.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

8.  The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.

Authors:  Haibo Zhang; Aihua Lin; Ping Gong; Yanqing Chen; Richard D Ye; Feng Qian; Yan Zhang; Yang Yu
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

Review 9.  Synergy between amyloid-β and tau in Alzheimer's disease.

Authors:  Marc Aurel Busche; Bradley T Hyman
Journal:  Nat Neurosci       Date:  2020-08-10       Impact factor: 24.884

10.  Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.

Authors:  Maud Gratuze; Cheryl Eg Leyns; Andrew D Sauerbeck; Marie-Kim St-Pierre; Monica Xiong; Nayeon Kim; Javier Remolina Serrano; Marie-Ève Tremblay; Terrance T Kummer; Marco Colonna; Jason D Ulrich; David M Holtzman
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.